Belimumab With Rituximab for Primary Membranous Nephropathy
for
Membranous Nephropathy, Nephrotic Syndrome
Location: 20 recruiting locations
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70+
Code: NCT03949855
Phase2, Recruiting
Active & Responsive
Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
for
Lupus Nephritis
Location: 6 recruiting locations
Sponsor: NephroNet, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07225387
Recruiting
Active & Responsive
Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)
for
IgA Nephropathy (IgAN)
Location: 2 recruiting locations
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06676579
Phase2, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
for
Primary IgA Nephropathy
Location: 35 recruiting locations
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05797610
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
TESTING -ON Post-Trial ObservatioNal Cohort Study
for
IgA Nephropathy, ESRD, Glomerulonephritis, Kidney Diseases
Location: 2 recruiting locations
Sponsor: The George Institute
Sex: All
Age: 18 - 70+
Code: NCT05434325
Recruiting
Obinutuzumab in Treatment of Fibrillary Glomerulonephritis
for
Fibrillary Glomerulonephritis
Location: 1 recruiting location
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06295770
Phase2, Recruiting
Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits
for
Proliferative Glomerulonephritis With Monoclonal IgG Deposits
Location: 3 recruiting locations
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT05654506
Phase2, Recruiting
Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)